Lei Yang, Qing Gao, Jun Gong, Jinmin Hu, Xiangru Shi, Jin Peng, Han Wu, You Wang, Hui Xu, Xin Long, Qing Yin, Fuxiang Zhou. "Surufatinib combined with anti-PD-1/PD-L1 antibody in the second line or monotherapy in third line treatment of advanced hepatocellular carcinoma: A single-arm, open-label, multi-center phase II study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16172